Trials / Completed
CompletedNCT03195062
Fructose Extra-splanchnic Metabolism and Its Effects on Systemic Flux of Substrates (FruPP)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- University of Lausanne · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
In parallel to the dramatic rise in metabolic diseases and diabetes observed over the past fifty years, the generalization of added sugar in processed food led to a marked increase in fructose consumption in almost all countries, and epidemiological studies demonstrated that the consumption of sugar-sweetened beverage (containing at least 50% of fructose) is associated with the development of diabetes, hepatic steatosis, dyslipidemia and obesity. The objective of the study is to measure the amount of fructose that escape first-pass hepatic extraction after oral ingestion (fructose+glucose), and gain insights into its metabolic fates with the use of tracers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Test meal | Liquid test meal (fructose+glucose) |
Timeline
- Start date
- 2017-03-23
- Primary completion
- 2018-06-30
- Completion
- 2018-08-31
- First posted
- 2017-06-22
- Last updated
- 2018-10-18
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03195062. Inclusion in this directory is not an endorsement.